Skip to main content

Abbvie Inc(ABBV-N)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low137.10
Day High139.85
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Press & news

Latest News

2 Dividend Kings on Sale That Are Yielding More Than 4%
Motley Fool - Thu May 25, 8:37AM CDT
Motley Fool
Thu May 25, 8:37AM CDT
Before you rush out to buy these stocks, you should consider the risks that come with them.
2 Top Dividend Kings to Buy for the Long Haul
Motley Fool - Thu May 25, 8:00AM CDT
Motley Fool
Thu May 25, 8:00AM CDT
Dividend stocks are an easy way to earn passive income.
New England Journal of Medicine Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib (RINVOQ®) in Crohn's Disease
PR Newswire - Thu May 25, 7:45AM CDT
PR Newswire
Thu May 25, 7:45AM CDT
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the New England Journal of Medicine (NEJM) published results from the pivotal Phase 3 clinical trials –...

Latest Articles